IRIS
FIORILLO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.449
NA - Nord America 2.439
EU - Europa 1.213
SA - Sud America 702
AF - Africa 184
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 7.002
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.336
SG - Singapore 1.014
BR - Brasile 522
CN - Cina 464
VN - Vietnam 402
IT - Italia 305
UA - Ucraina 240
DE - Germania 215
HK - Hong Kong 109
FR - Francia 101
IN - India 74
SN - Senegal 73
AR - Argentina 70
SE - Svezia 65
KR - Corea 62
FI - Finlandia 55
BD - Bangladesh 51
TR - Turchia 51
AT - Austria 46
CA - Canada 46
IQ - Iraq 44
ZA - Sudafrica 41
MX - Messico 40
GB - Regno Unito 39
RU - Federazione Russa 33
ID - Indonesia 24
CO - Colombia 20
EC - Ecuador 20
PK - Pakistan 20
MA - Marocco 19
PL - Polonia 19
VE - Venezuela 19
JP - Giappone 17
NL - Olanda 17
BE - Belgio 13
CL - Cile 13
PY - Paraguay 12
UZ - Uzbekistan 12
ES - Italia 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
IL - Israele 10
MY - Malesia 10
PE - Perù 10
AU - Australia 9
KE - Kenya 9
PH - Filippine 9
JO - Giordania 8
TN - Tunisia 8
BG - Bulgaria 7
BO - Bolivia 7
DZ - Algeria 7
UY - Uruguay 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
IR - Iran 5
JM - Giamaica 5
LB - Libano 5
NP - Nepal 5
PS - Palestinian Territory 5
TH - Thailandia 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
ET - Etiopia 4
EU - Europa 4
KZ - Kazakistan 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
HU - Ungheria 3
LV - Lettonia 3
OM - Oman 3
SI - Slovenia 3
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MK - Macedonia 2
MT - Malta 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CM - Camerun 1
DM - Dominica 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GY - Guiana 1
Totale 6.988
Salva come PNG Salva come JPEG
Città #
Singapore 417
Chandler 292
San Jose 210
Dallas 192
Ashburn 165
Beijing 143
Ho Chi Minh City 137
Jacksonville 137
New York 136
Boardman 134
Hong Kong 108
Hanoi 102
San Mateo 83
Dakar 73
Dearborn 67
Rende 65
Seoul 62
Shanghai 58
Lauterbourg 53
Hefei 47
Lawrence 44
Roxbury 44
Los Angeles 41
São Paulo 40
Helsinki 39
Munich 33
Brooklyn 31
Da Nang 28
Vienna 28
Izmir 26
Florence 24
Rio de Janeiro 24
Baghdad 23
Des Moines 21
Ottawa 21
Seattle 21
The Dalles 20
Frankfurt am Main 19
Santa Clara 19
Catanzaro 18
Tokyo 16
Cosenza 15
Haiphong 15
Mexico City 15
Chennai 14
Hải Dương 14
Brussels 13
Cambridge 13
Council Bluffs 13
Inglewood 13
Johannesburg 13
San Francisco 13
Warsaw 13
Turku 12
Biên Hòa 11
Columbus 11
Dhaka 11
Guangzhou 11
Ogden 11
Orem 11
Porto Alegre 11
Guarulhos 10
Hanover 10
Montreal 10
Rome 10
Tashkent 10
Wilmington 10
Amsterdam 9
Bari 9
Boston 9
Milan 9
Naples 9
New Delhi 9
Stockholm 9
Toronto 9
Belo Horizonte 8
Falkenstein 8
Manchester 8
Amman 7
Ann Arbor 7
Bremen 7
Caracas 7
Catania 7
Juiz de Fora 7
London 7
Medellín 7
Ninh Bình 7
Pune 7
Atlanta 6
Cairo 6
Grafing 6
Guayaquil 6
Kuala Lumpur 6
Lahore 6
Lima 6
Nairobi 6
Salvador 6
Thái Nguyên 6
Uberlândia 6
Ankara 5
Totale 3.811
Salva come PNG Salva come JPEG
Nome #
Polyunsaturated Fatty Acids and their Role in the Diet of Cancer Patients: An Overview 221
Bergamot (citrus bergamia risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: An overview 198
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism 196
5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer 194
17-Hydroxyprogesterone/Progesterone Receptor B Signalling Disrupts the Metabolic Reprogramming in Breast Cancer Cell Lines 181
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 179
Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway 172
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) 168
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 168
A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like Mode 161
Enhanced cellular uptake by "pharmaceutically oriented devices" of new simplified analogues of Linezolid with antimicrobial activity 160
Antibacterial activity of new Beta-lactam compounds 158
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 157
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 150
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 149
Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies 146
Characterization of new mitochondrial carriers in Drosophila melanogaster”. 143
ERRα PATHWAY AND ENDOCRINE RESISTANCE ON BREAST CANCER: CHOLESTEROL AND MEVALONATE INVOLVEMENT 142
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 134
Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy 130
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast 126
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 125
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production 122
Thioalbamide, a thioamidated peptide from Amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress 113
New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier 112
Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) 111
GENOMICS-BASED DISCOVERY AND ANTICANCER ACTIVITY ASSESSMENT OF NEW THIOVIRIDAMIDE-LIKE MOLECULES PRODUCED BY ACTINOBACTERIA 108
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 108
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells 108
New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration 106
Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): "In vivo" studies 106
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase 103
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via "differentiation-based nano-therapy" 101
"Energetic" cancer stem cells (e-CSCs): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy 100
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 99
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 96
Oxazolidinones-mediated mitochondrial dysfunction promotes cell death and cancer stemness inhibition in breast and cervical cancer 95
Mass Spectrometry-Based Proteomic Approach in Oenococcus oeni Enological Starter 93
Two functionally different mitochondrial phosphate carriers support Drosophila melanogaster OXPHOS throughout distinct developmental stages 92
Impact of COVID-19 Lockdown on Metabolic/Inflammatory Profile in Adolescents: Cellular Studies and Predictive Biomarkers 88
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 87
The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment 86
Multifunctional Microspheres Based on D-Mannose and Resveratrol for Ciprofloxacin Release 85
Novel CD44-Targeted Albumin Nanoparticles: An Innovative Approach to Improve Breast Cancer Treatment 85
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 83
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells 80
Exploiting Glycyrrhiza glabra L. (Licorice) Flavanones: Licoflavanone’s Impact on Breast Cancer Cell Bioenergetics 78
Sntesi ed attività antimicrobica di nuovi derivati b-lattamici 77
Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models 76
New Oxazolidin-2-ones of antimicrobial activity 73
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer 71
New β-Lactam derivatives: synthesis and antimicrobial properties. 71
Merging fusogenic DOPE and a tumour targeted self-assembling biopolymer: Smart hybrid liposomes for drug vectorization in cancer therapy 70
New Oxazolidin-2-ones with antimicrobial activity 70
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy 69
New simplified analogues of linezolid with antimicrobial activity. 67
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy 64
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling 58
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 54
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 53
Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia 51
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs) 46
Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy 45
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics 45
Biomarkers of multimorbidity: A systematic review 23
Adipocyte‑derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross‑talk between cancer cells and the tumor microenvironment 20
Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor–Positive Breast Cancer Cells 17
Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction 13
Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs 11
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration 9
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells 8
Totale 7.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 28 7 24
2021/2022466 9 61 2 20 45 9 2 98 21 3 68 128
2022/2023774 100 80 21 79 103 55 13 111 95 27 59 31
2023/2024595 67 20 35 16 31 183 21 29 62 33 16 82
2024/20251.247 86 149 19 74 79 74 90 73 192 88 112 211
2025/20263.393 418 237 346 287 582 244 462 224 306 287 0 0
Totale 7.164